Inventor · disambiguated record
David Kiewlich
Also filed as: KIEWLICH DAVID
6 granted patents·6 pending applications·4 citations·filing 2010–2024
75Inventor score
Top patents by PatentIndex Score
12 records- 0186US10696950B2Treating diabetes with genetically modified beta cellsWALLKILL BIOPHARMA INC·Filed 2019·Granted Jun 30, 2020·4 cites·7 claims
- 0286US2024360418A1Methods for reducing elevated glucose levelsSDF BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 0385US12365876B2Genetically modified stem cellsSDF BIOPHARMA INC·Filed 2023·Granted Jul 22, 2025·0 cites·28 claims
- 0477US11739298B2Genetically modified stem cellsSDF BIOPHARMA INC·Filed 2021·Granted Aug 29, 2023·0 cites·10 claims
- 0574US11186827B1Genetically modified stem cellsSDF BIOPHARMA INC·Filed 2021·Granted Nov 30, 2021·0 cites·3 claims
- 0671US10982190B2Genetically modified stem cellsSDF BIOPHARMA INC·Filed 2020·Granted Apr 20, 2021·0 cites·15 claims
- 0769US11981928B2Methods for reducing elevated glucose levelsSDF BIOPHARMA INC·Filed 2018·Granted May 14, 2024·0 cites·5 claims
- 0855US2024024371A1Treating diabetesSDF BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 0948US2016074483A1Therapeutic peptide-expressing cellsINFINITE CELLS LLC·Filed 2014·Application pending·0 cites
- 1047US2023149511A1Treating autoimmune diseases with genetically modified cellsWALLKILL BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 1140US2012178693A1Cofactors for Thrombin Activation of Factor VII and Uses ThereofLIGHT DAVID·Filed 2010·Application pending·0 cites
- 1239US2019390221A1Plasmid vectors for expression of large nucleic acid transgenesKIEWLICH DAVID·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →